J Korean Soc Neonatol.  2006 May;13(1):184-188.

Successful Treatment of Candida albicans Endocarditis with Liposomal Amphotericin B (AmBisome(R)) in a Very Low Birth Weight Infant

Affiliations
  • 1Department of Pediatrics, College of Medicine, Hallym University, Seoul, Korea. ithwang83@hallym.or.kr

Abstract

Candida albicans endocarditis is an uncommon manifestation of systemic candidiasis in newborn infants who require intensive care and develops mostly in patients with congenital heart disease; open heart surgery is the majority of predisposing factor. Improvement of techniques managing premature infants leads to increased survival rates, which give much more chances to develop fungal infections and its complications. We report a case of very low birth weight infant who had candidemia and Candida endocarditis, who was successfully treated with AmBisome(R) because of no response to conventional amphotericin B therapy.

Keyword

Neonate; Candida albicans; Endocarditis; Liposomal Amphotericin B

MeSH Terms

Amphotericin B*
Candida albicans*
Candida*
Candidemia
Candidiasis
Causality
Endocarditis*
Heart Defects, Congenital
Humans
Infant, Newborn
Infant, Premature
Infant, Very Low Birth Weight*
Critical Care
Survival Rate
Thoracic Surgery
Amphotericin B
Full Text Links
  • JKSN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr